Suppr超能文献

TSC1基因的错义突变会导致结节性硬化症。

Missense mutations to the TSC1 gene cause tuberous sclerosis complex.

作者信息

Nellist Mark, van den Heuvel Diana, Schluep Diane, Exalto Carla, Goedbloed Miriam, Maat-Kievit Anneke, van Essen Ton, van Spaendonck-Zwarts Karin, Jansen Floor, Helderman Paula, Bartalini Gabriella, Vierimaa Outi, Penttinen Maila, van den Ende Jenneke, van den Ouweland Ans, Halley Dicky

机构信息

Department of Clinical Genetics, Erasmus Medical Centre, Rotterdam, The Netherlands.

出版信息

Eur J Hum Genet. 2009 Mar;17(3):319-28. doi: 10.1038/ejhg.2008.170. Epub 2008 Oct 1.

Abstract

Tuberous sclerosis complex (TSC) is an autosomal dominant disorder characterised by the development of hamartomas in a variety of organs and tissues. The disease is caused by mutations in either the TSC1 gene on chromosome 9q34 or the TSC2 gene on chromosome 16p13.3. The TSC1 and TSC2 gene products, TSC1 and TSC2, interact to form a protein complex that inhibits signal transduction to the downstream effectors of the mammalian target of rapamycin (mTOR). Here we investigate the effects of putative TSC1 missense mutations identified in individuals with signs and/or symptoms of TSC on TSC1-TSC2 complex formation and mTOR signalling. We show that specific amino-acid substitutions close to the N-terminal of TSC1 reduce steady-state levels of TSC1, resulting in the activation of mTOR signalling and leading to the symptoms of TSC.

摘要

结节性硬化症(TSC)是一种常染色体显性疾病,其特征是在多种器官和组织中形成错构瘤。该疾病由位于9号染色体q34上的TSC1基因或16号染色体p13.3上的TSC2基因突变引起。TSC1和TSC2基因产物TSC1和TSC2相互作用形成一种蛋白质复合物,该复合物抑制信号转导至雷帕霉素哺乳动物靶点(mTOR)的下游效应器。在此,我们研究了在有TSC体征和/或症状的个体中鉴定出的假定TSC1错义突变对TSC1-TSC2复合物形成和mTOR信号传导的影响。我们发现,靠近TSC1 N端的特定氨基酸取代会降低TSC1的稳态水平,导致mTOR信号传导激活并引发TSC症状。

相似文献

1
Missense mutations to the TSC1 gene cause tuberous sclerosis complex.
Eur J Hum Genet. 2009 Mar;17(3):319-28. doi: 10.1038/ejhg.2008.170. Epub 2008 Oct 1.
3
A reliable cell-based assay for testing unclassified TSC2 gene variants.
Eur J Hum Genet. 2009 Mar;17(3):301-10. doi: 10.1038/ejhg.2008.184. Epub 2008 Oct 15.
4
Functional assessment of TSC2 variants identified in individuals with tuberous sclerosis complex.
Hum Mutat. 2013 Jan;34(1):167-75. doi: 10.1002/humu.22202. Epub 2012 Oct 11.
5
Functional assessment of TSC1 missense variants identified in individuals with tuberous sclerosis complex.
Hum Mutat. 2012 Mar;33(3):476-9. doi: 10.1002/humu.22007. Epub 2012 Jan 17.
10
Large deletion at the TSC1 locus in a family with tuberous sclerosis complex.
Genet Test. 2005 Fall;9(3):226-30. doi: 10.1089/gte.2005.9.226.

引用本文的文献

1
Splicing Analysis of Exonic TSC1 and TSC2 Gene Variants Causing Tuberous Sclerosis Complex.
Hum Mutat. 2025 Apr 1;2025:1497712. doi: 10.1155/humu/1497712. eCollection 2025.
3
The Correlation Between Tuberous Sclerosis Complex Genotype and Renal Angiomyolipoma Phenotype.
Front Genet. 2021 Feb 19;11:575750. doi: 10.3389/fgene.2020.575750. eCollection 2020.
4
Mutational analysis of TSC1 and TSC2 genes in Tuberous Sclerosis Complex patients from Greece.
Sci Rep. 2017 Dec 1;7(1):16697. doi: 10.1038/s41598-017-16988-w.
6
Differentiating the mTOR inhibitors everolimus and sirolimus in the treatment of tuberous sclerosis complex.
Neuro Oncol. 2015 Dec;17(12):1550-9. doi: 10.1093/neuonc/nov152. Epub 2015 Aug 19.
7
Genotype and cognitive phenotype of patients with tuberous sclerosis complex.
Eur J Hum Genet. 2012 May;20(5):510-5. doi: 10.1038/ejhg.2011.241. Epub 2011 Dec 21.
8
Determining the pathogenicity of patient-derived TSC2 mutations by functional characterization and clinical evidence.
Eur J Hum Genet. 2011 Jul;19(7):789-95. doi: 10.1038/ejhg.2011.38. Epub 2011 Mar 16.
9
Characterisation of TSC1 promoter deletions in tuberous sclerosis complex patients.
Eur J Hum Genet. 2011 Feb;19(2):157-63. doi: 10.1038/ejhg.2010.156. Epub 2010 Sep 29.
10
Phosphatidylinositol 3-kinase (PI3K) pathway activation in bladder cancer.
Cancer Metastasis Rev. 2009 Dec;28(3-4):305-16. doi: 10.1007/s10555-009-9198-3.

本文引用的文献

1
Bladder tumour-derived somatic TSC1 missense mutations cause loss of function via distinct mechanisms.
Hum Mol Genet. 2008 Jul 1;17(13):2006-17. doi: 10.1093/hmg/ddn098. Epub 2008 Apr 7.
2
Overlapping neurologic and cognitive phenotypes in patients with TSC1 or TSC2 mutations.
Neurology. 2008 Mar 18;70(12):908-15. doi: 10.1212/01.wnl.0000280578.99900.96. Epub 2007 Nov 21.
6
Sacrococcygeal chordomas in patients with tuberous sclerosis complex show somatic loss of TSC1 or TSC2.
Genes Chromosomes Cancer. 2004 Sep;41(1):80-5. doi: 10.1002/gcc.20052.
7
TSC2: filling the GAP in the mTOR signaling pathway.
Trends Biochem Sci. 2004 Jan;29(1):32-8. doi: 10.1016/j.tibs.2003.11.007.
10
TSC2 is phosphorylated and inhibited by Akt and suppresses mTOR signalling.
Nat Cell Biol. 2002 Sep;4(9):648-57. doi: 10.1038/ncb839.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验